WoundReference improves clinical decisions
 Choose the role that best describes you
Janowska A, Papa G, Romanelli M, Davini G, Oranges T, Stocco C, Arnez ZM, Dini V, et al.
Journal of investigative surgery : the official journal of the Academy of Surgical Research. Date of publication 2022 Jan 1;volume 35(1):49-52.
1. J Invest Surg. 2022 Jan;35(1):49-52. doi: 10.1080/08941939.2020.1821134. Epub 2020 Sep 24. 5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study. Janowska A(1), Papa G(2), Romanelli M(1), Davini G(1), Oranges T(1)(3), Stocco C(2), Arnez ZM(2), Dini V(1). Author information: (1)Department of Dermatology, University of Pisa, Pisa, Italy. (2)Department of, Medical, Surgical and Health Sciences, Plastic and Reconstructive Surgery Unit, University of Trieste, Trieste, Italy. (3)Department of Health Sciences, Anna Meyer Children University Hospital, University of Florence, Florence, Italy. BACKGROUND: Lidocaine hydrochloride is frequently used for management of painful wounds. This prospective, multicentre study examined the effects of 5% lidocaine cream on wound pain relief. MATERIAL AND METHODS: The study included 78 patients with painful wounds treated with 5% Lidocaine cream for two weeks in two Italian Hospitals. Patients' perception of pain was recorded by, using the 5-point Visual Rate Scale and the 11-point Numerical Pain Rating Scale. All medications and adverse events were evaluated in a daily diary. The primary outcome of the study was establishing the wound pain relief based on the results of 5-VRS and pain intensity based on the 11-NPRS testing from baseline to the end of treatment. Clinical aspects and adverse events were also collected. RESULTS: Seventy-eight patients had a median age of 67.5 years (range 18-96 years). 62.8% were women. The wounds included traumatic wounds (n = 39), venous ulcers (n = 25), post-surgical wounds (n = 6) pyoderma gangrenosum (n = 6), vasculitis (n = 1) and pressure ulcer (n = 1). The intensity of pain significantly decreased from the baseline level established at the beginning of treatment (mean score 6.7 - 1.90) - to the level at end of treatment (3.0 - 2.23-; p < 0.0001). 9 patients prematurely stopped the treatment for healing (n = 4), wound improvement (n = 2) and adverse events related to the treatment. (n = 3). 13 patients presented a total of 25 adverse events, 4 of them were related to the treatment. CONCLUSION: The treatment of painful wounds with 5% Lidocaine Cream for 14 days resulted in reduced pain intensity, and showed high safety and tolerability. DOI: 10.1080/08941939.2020.1821134 PMID: 32969736 [Indexed for MEDLINE]
Appears in following Topics:
How to Administer Local Anesthesia for Wound Care Procedures